Christopher Scott

Professor

  • Room 03.002 - CCRCB

    United Kingdom

Accepting PhD Students

20002020

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Interests

Nanomedicine, Antibodies, Antibody-Drug Conjugates (ADCs), cathepsin proteases, cancer, inflammation, infection

Research Statement

Professor Chris Scott is Director of the Patrick G Johnston Centre for Cancer Research.  Following a primary degree in Biochemistry he undertook a PhD and post doctoral training at Queen’s in molecular enzymology.  In 2001, Chris was one of the founding members of QUB spinout company Fusion Antibodies Ltd., before returning to Queen’s in 2003 to take up an academic position.  Chris is internationally renowned for his work in development of antibody and nanomedicine-based therapies for the treatment of cancer and other conditions.  Work in his laboratory is funded by agencies such as Medical Research Council, US-Ireland, and various industrial sources such as AstraZeneca and Immunocore.  He also held a Royal Society Industrial Fellowship with GSK from 2012-15, and won the Vice Chancellor’s Prize for Innovation in 2015 with his group’s work on developing a novel nanomedicine for the treatment of sepsis and other inflammatory conditions. Chris is a member of the Medical Research Council Developmental Pathway Funding Scheme Panel.

Fingerprint

Dive into the research topics where Christopher Scott is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 9 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or
If you made any changes in Pure these will be visible here soon.